1. Synchronous NET and colorectal cancer development: a case report
- Author
-
Shiro Iwagami, Masaaki Iwatsuki, Yoshifumi Baba, Takahiko Akiyama, Hideo Baba, Yukiharu Hiyoshi, Yuki Kiyozumi, Yohei Nagai, Shinsei Yumoto, Yuji Miyamoto, Kojiro Eto, and Naoya Yoshida
- Subjects
Oncology ,medicine.medical_specialty ,Prognostic factor ,Colorectal cancer ,lcsh:Surgery ,Case Report ,Neuroendocrine tumors ,Systemic therapy ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,Everolimus ,business.industry ,Incidence (epidemiology) ,Cancer ,lcsh:RD1-811 ,medicine.disease ,NET ,030220 oncology & carcinogenesis ,030211 gastroenterology & hepatology ,Laparoscopic sigmoidectomy ,business ,medicine.drug - Abstract
Background The incidence of synchronous gastrointestinal neuroendocrine tumors (GI-NETs) and colorectal cancer is very low. Case presentation We present a 72-year-old man diagnosed with a rectal neuroendocrine tumor (NET) with multiple organ metastases and simultaneous sigmoid colon cancer. Although the NET was his prognostic factor, he underwent a laparoscopic sigmoidectomy at first because it was expected that the colon cancer would cause obstruction or bleeding during NET treatment. Subsequently, he started taking everolimus. Conclusions We should consider surgical resection of the synchronous cancer before systemic therapy for a GI-NET regardless of the difference in prognosis between synchronous tumors, if the cancer may impair the continuation of systemic therapy.
- Published
- 2020